DLA Piper advises on Sperco Ukraine investment
DLA Piper Ukraine has advised Europe Virgin Fund (EVF), a private equity fund, sponsored by Dragon Capital in set up of a joint venture with Ucrafarma SA.
The parties invested into Lux PHARMA Participations SA, a Luxembourg-based holding company, with Ucrafarma SA transferring various pharmaceutical assets including its 95 per cent stake in Sperco Ukraine LLC, one of the top 10 pharmaceutical manufacturers of Ukraine, and EVF providing capital for further development
DLA Piper provided full legal support to the transaction, including legal due diligence of Ukrainian and Spanish assets, drafting and negotiating transactional documents governed by English, Ukrainian and Spanish law, support of closing of the deal.
The DLA Piper team was led by legal director Illya Muchnyk under the general supervision of managing partner Margarita Karpenko. The significant input was provided by finance and projects associates Dmytro Pshenychnyuk, Maxim Andrianov, Dmytro Lapa and real estate associates — Oleg Matiusha.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
DLA Piper has released the winter 2014 issue of SHE Matters, a newsletter dedicated to safety, health and the environment.
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal and regulatory landscape.
Analysis from The Lawyer
The fragile refinance market is back in rude health and US-style alternative lenders are stepping up with innovative structures to sustain the recovery
The Lawyer’s latest Top 50 litigation firms list shows that business for dispute specialists is roaring along while new in-depth detail reveals the winning strategies